Breaking News

Measure to Manage: How Data-Driven Feedback Drives up Patient Adherence in Clinical Trials

Every clinical trial participant with poor medication adherence will have their own set of complex reasons for not taking their medications as prescribed – meaning there is no one size fits all solution. Instead, sponsors should take a data-driven approach that utilizes focused feedback, guides individualized interventions, and has been shown to be capable of…

Read More

Setting the Stage for Better Medication Adherence in Clinical Trials

Better medication adherence in clinical trials

When clinical trial participants do not follow the dosing protocol, it can result in an underestimation of a drug’s therapeutic effect. With inability to demonstrate efficacy being the leading cause of study failure worldwide1, it’s an issue sponsors cannot afford to ignore – and with digitally enabled medication adherence packaging, they no longer have to.…

Read More

How Effective Are Digital Pills at Measuring Medication Adherence?

While digital pills have long been hailed as a valuable solution to the stubborn medication adherence problem, there have been questions about their use, in terms of intrusiveness, acceptance, and reliability. But with the evidence base expanding, there are opportunities to embrace the paradigm-shifting potential of this innovative solution. A stubborn challenge It’s no secret…

Read More

EFPIA Calls for Greater Clarity Around the Regulatory Role of Digital Health Technology

Digital health technologies (DHT), including digital medication adherence monitoring, have the potential to revolutionize drug development, and must be given every opportunity to succeed.  That’s according to the European Federation of Pharmaceutical Industries and Associations (EFPIA) reflection paper, which has called for greater clarity and harmonization around how digital solutions fit into the regulatory pathway.…

Read More

How AARDEX Group’s Medication Adherence Technology Helped Iroko Gain FDA Approval

Proving the efficacy of investigational products is a complex process but with the right Medication Adherence Technology, sponsors can generate the evidence that they need to get drugs from labs to life, faster. Unmet Medical Need Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to combat pain, reduce inflammation, and reduce high temperatures.…

Read More

Pfizer Acknowledges the Need for Better Medication Adherence in Clinical Trials

medication adherence in clinical trials

Drug giant, Pfizer has highlighted the need for effective, patient-centered medication adherence management in clinical trials. Nothing stops a drug from working more than not taking it, but, as medicine and leadership pioneer and Pfizer’s Chief Medical Officer, said, non-adherence in clinical trials damages more than the patient.  “It is also corrosive to the integrity…

Read More

AARDEX Group and BIOCORP Recruited by [email protected] – Decentralized Trial Centre of Excellence

Trials@Home Press Release

Combining BIOCORP’s pen injector add-on with AARDEX® Group’s Software to improve adherence to medication in a Hybrid Phase IV Diabetes Study. Liege, Belgium – July 19, 2022: Following the launch of their global collaboration to support medication adherence in different fields last year, Belgium-based AARDEX GROUP, the leader in tools for measuring and managing adherence to medication in…

Read More

ESPACOMP Backs Electronic Medication Monitoring as “Method of Choice” for Quantifying Medication Adherence in Clinical Trials

electronic medication monitoring

Effectively measuring medication adherence relies on selecting the most appropriate data source – and for clinical trials, that data source is electronic medication monitoring. The TEOS (timelines-events-objectives-source) guideline provides a clear framework on how to assess medicine-taking behavior relative to the scenario, and a new review paper makes clear that electronic medication monitoring is the…

Read More